Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting protein kinases involved in cancer and inflammatory diseases. Its structure supports the development of selective inhibitors due to its ability to mimic purine motifs in ATP-binding sites. Also employed in the design of neuroprotective agents and compounds targeting central nervous system disorders. Commonly found in early-stage drug discovery for optimizing lead compounds with improved binding affinity and metabolic stability.